Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Key Ratios

Key Ratios

Price & Volume

Recent Price $11.39
52 Week High $20.55
52 Week Low $11.08
Volume (10 Day Average) (Mil) $0.28
Beta $0.71

Dividends

Yield (%) --
Ex-Dividend Date
Dividend Rate --%

Financial Strength

Quick Ratio (MRQ) --
Current Ratio (MRQ) $4.65
LT Debt to Equity (MRQ) (%) --
Total Debt to Equity (MRQ) (%) --

Valuation

P/E (TTM) --
Price to Revenue (TTM) $724.42
Price to Cash Flow (TTM) --
Price to Book (MRQ) $5.68

Per Share

Revenue/Share (TTM) $0.02
EPS Fully Diluted (MRQ) $-0.73
Book Value/Share (MRQ) $2.01
Cash Flow/Share (TTM) $-2.97
Cash (MRQ) $2.48

Management Effectiveness

Return on Equity (TTM) (%) -123.50
Return on Assets (TTM) (%) -99.06
Return on Investment (TTM) (%) -123.30

Profitability

Operating Margin (TTM) (%) -16,259.49
Net Profit Margin (TTM) (%) -16,027.75
Gross Margin (TTM) (%) --


Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved